ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients

T. Shaker1, K. Ramanathan1, S. Riad2, D. Vock3, S. Chinnakotla1

1Surgery, Division of Transplantation, University of Minnesota, Minneapolis, MN, 2Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, 3Biostatistics, University of Minnesota, Minneapolis, MN

Meeting: 2020 American Transplant Congress

Abstract number: 585

Keywords: Graft survival, Immunosuppression, Induction therapy, Pediatric

Session Information

Session Name: Liver: Pediatrics

Session Type: Oral Abstract Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:51pm-4:03pm

Location: Virtual

*Purpose: Induction immunosuppression for pediatric liver transplants varies widely among centers. We sought to evaluate the impact of different induction regimens on patient and graft survival.

*Methods: SRTR database was used to identify all pediatric primary liver transplant recipients between 2002-2016 who were discharged on tacrolimus, or tacrolimus and mycophenolate maintenance with or without steroids. Patients were grouped by type of induction into no induction, depletional, and non-depletional (IL-2) groups. Mixed effects proportional hazards and logistic regression models were fit to assess the association of induction therapy on graft and patient survival, and acute rejection in the first 6 and 12 months after adjusting for recipient and donor characteristics. Transplant center was included as a random effect in these models.

*Results: 5194 recipients met inclusion criteria, 473 received depletional induction, 968 received IL-2 inhibitors and 3753 received no induction. Patients receiving depletional (aHR:0.59, 95% CI:0.39-0.91) and IL-2 (aHR:0.88, 95% CI:0.45-1.72) had higher patient survival compared to those receiving no induction therapy (Figure 1). There were no significant differences in graft survival between the groups (p=0.13). Those receiving IL-2 were less likely to have an acute rejection episode within the first 12 months post-transplant compared to those receiving no induction (aOR: 0.74, 95% CI: 0.61-0.91, p=0.004), but there was no difference in acute rejection between those receiving depletional and no induction (aOR:1.15, 95% CI:0.89-1.48) (Table 1). There was no difference in the cause-specific hazard of death due to infection (p=0.63) among the groups.

*Conclusions: In this large cohort of pediatric primary liver transplant recipients, use of depletional induction was associated with higher patient survival. Use of IL-2 inhibitors was associated with lower rejection rates within 12 months. Our findings suggest that a biologic induction may be beneficial in primary pediatric liver transplant recipients.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Shaker T, Ramanathan K, Riad S, Vock D, Chinnakotla S. Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/induction-immunosuppression-in-primary-pediatric-liver-transplant-recipients/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences